Status:
UNKNOWN
The Prophylaxis of Tuberculosis According to TSPOT Results After Kidney Transplantation
Lead Sponsor:
West China Hospital
Conditions:
Kidney Transplant Infection
Tuberculosis
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Organ transplant recipients are a high incidence group of tuberculosis infection, and the incidence rate is 7-27 times that of the general population. The prevention of postoperative tuberculosis infe...
Eligibility Criteria
Inclusion
- living-donor kidney transplantation;
- eGFR level \> 45ml/min/1.73m2 at discharge;
- 18\<Age \<65years;
- receiving standard triad immunosuppressive regimen
Exclusion
- alanine aminotransferase (ALT) or aspartate aminotransferase (AST) \> 2.5 or more of upper limit of normal
- Combined with HBV/HCV/HIV/TB infection in the donor or recipient;
- Malignancy history in the donor and recipient;
- organ transplant history in the recipient.
- The positive TSPOT result or past TB history in the donor
Key Trial Info
Start Date :
April 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 1 2023
Estimated Enrollment :
303 Patients enrolled
Trial Details
Trial ID
NCT05249699
Start Date
April 1 2022
End Date
August 1 2023
Last Update
April 4 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.